Thanks Treed great post. I would like to add that another reason Meso is still going after Chrohns is because Meso cells are second generation technology. Potency is much much stonger.
Trials with tigenix cells were started 10 yrs ago and tbey still showed great results compared to standard of care.Meso will beat them easily.
There is quite a bit of literature written about the new and old cells that Meso uses.
In fact GVHD cells is old technology compared to our cellls used for heart and back pain.
And if you think about it those first generation cells worked very very well.
Just wait for readouts of the more potent second generation cells....They will blow some minds imo.
- Forums
- ASX - By Stock
- MSB
- Licensees and MSCs
MSB
mesoblast limited
Add to My Watchlist
12.3%
!
$2.43
Licensees and MSCs, page-12
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
